Dilaudid Uses, Dosage & Side Effects

You should also talk about your safety if you have a history of drug abuse or addiction. These drugs can be addictive and increase your risk of overdose and death. Both medications belong to a class of drugs called opioid analgesics, also known as narcotics. This action changes the way you perceive pain to help you to feel less pain.

Serious side effects of Dilaudid

This can happen when it doesn’t produce enough of the hormone insulin, the body can’t use it properly, or both. If you use DDAVP nasal spray or tablets, you’ll start to produce less urine within an hour or two. It occurs when the body doesn’t make enough ADH, usually as a result of something like an infection, tumor, or traumatic brain injury barbiturates (TBI). Diabetes insipidus (DI) is a rare disorder of the endocrine system (relating to the glands in your body that produce hormones). DI occurs when the body encounters challenges in either producing or responding to the antidiuretic hormone (ADH), also known as vasopressin. A key difference between these drugs is the forms they come in.

Dosage Modifications in Patients with Hepatic Impairment

Inform patients of the risk of life-threatening respiratory depression, including information that the risk is greatest when starting DILAUDID Oral Solution or DILAUDID Tablets or when the dosage is increased, and that it can occur even at recommended dosages. Hydromorphone is a full opioid agonist and is relatively selective for the mu-opioid receptor, although it can bind to other opioid receptors at higher doses. The principal therapeutic action of hydromorphone is analgesia.

Other Medical Problems

If taken on a routine basis, they each can also cause dependence (where you need to take a drug in order to feel normal). Check with your doctor right away if you have anxiety, restlessness, a fast heartbeat, fever, sweating, muscle spasms, twitching, nausea, vomiting, diarrhea, or see or hear things that are not there. These may be symptoms of a serious condition called serotonin syndrome. Your risk may be higher if you also take certain other medicines that affect serotonin levels in your body. Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur.

Use of DILAUDID Oral Solution and DILAUDID Tablets is contraindicated in patients with hypersensitivity to sulfite-containing medications. Do not abruptly discontinue DILAUDID Oral Solution or DILAUDID Tablets in a patient physically dependent on opioids. When discontinuing DILAUDID Oral Solution or DILAUDID Tablets in a physically dependent patient, gradually taper the dosage. Rapid tapering of hydromorphone in a patient physically dependent on opioids may bath salts abuse and addiction lead to a withdrawal syndrome and return of pain [see Dosage and Administration (2.7), Drug Abuse and Dependence (9.3)]. Regularly evaluate patients, particularly when initiating and titrating DILAUDID Oral Solution or DILAUDID Tablets and when DILAUDID is given concomitantly with other drugs that depress respiration [see Warnings and Precautions (5.3, 5.4), Drug Interactions (7)]. Alternatively, consider the use of non-opioid analgesics in these patients.

It is a priority for CBC to create products that are accessible to all in Canada including people with visual, hearing, motor and cognitive challenges. “Diverting medication is breaking trust with a clinician in a very significant way,” he said. “Some of the other things we do is move from a take home to an observed dose at pharmacies, which reduces the potential for them to make it into the community.”

However, this effect is not consistent and may be offset by an increased rate of cervical dilation, which tends to shorten labor. Monitor neonates exposed to opioid analgesics during labor for signs of excess sedation and respiratory depression. Opioid-Induced Hyperalgesia (OIH) occurs when an opioid analgesic paradoxically causes an increase in pain, or an increase in sensitivity to pain. This condition differs from tolerance, which is the need for increasing doses of opioids to maintain a defined effect [see Dependence (9.3)]. Symptoms of OIH include (but may not be limited to) increased levels of pain upon opioid dosage increase, decreased levels of pain upon opioid dosage decrease, or pain from ordinarily non-painful stimuli (allodynia). These symptoms may suggest OIH only if there is no evidence of underlying disease progression, opioid tolerance, opioid withdrawal, or addictive behavior.

1. If naloxone is prescribed, educate patients and caregivers on how to treat with naloxone [see Dosage and Administration (2.2), Warnings and Precautions (5.2, 5.4), Overdosage (10)].
2. If these challenges can be resolved with some pathway to drug decriminalization or legalization, one that stresses treatment and  law enforcement as necessary to ensure public health and safety, that’s fine.
3. RxList does not provide medical advice, diagnosis or treatment.

Typically, your doctor will start you on a low dosage and adjust it over time to reach the dosage that’s right for you. They’ll ultimately prescribe the smallest dosage that provides the desired effect. The injectable solutions are only given by a healthcare professional. In the geriatric population, age has no effect on the pharmacokinetics of hydromorphone.

In order to avoid developing withdrawal symptoms, instruct patients not to discontinue DILAUDID Oral Solution or DILAUDID Tablets without first discussing a tapering plan with the prescriber [see Dosage and Administration (2.7)]. Marked mydriasis rather than miosis may be seen with hypoxia in overdose situations [see Clinical Pharmacology (12.2)]. Infants born to mothers physically dependent on opioids will also be physically dependent and may exhibit respiratory difficulties and withdrawal signs [see Use in Specific Populations (8.1)].

To help avoid interactions, your doctor should manage all of your medications carefully. Be sure to tell your doctor about all medications, vitamins, or herbs you’re taking. To find out how this drug might interact with something else you’re taking, talk with your doctor or pharmacist. Hydromorphone oral tablet is generally used for short-term treatment. This drug comes with serious risks if you don’t take it as prescribed.

This document does not contain all possible side effects and others may occur. Check with your physician for additional information about side effects. Hydromorphone is listed under the German Betäubungsmittelgesetz as a Betäubungsmittel in the most restricted schedule for medicinal drugs; it is controlled similarly in Austria (Suchtgift) under the SMG and the Swiss BetmG. The Misuse of Drugs Act 1971 (United Kingdom) and comparable French, Canadian, Australian, Italian, Czech, Croatian, Slovenian, Swedish, Polish, Spanish, Greek, Russian, and other laws similarly control it, as do regulations in virtually all other countries. This medication has been prescribed for your current condition only.

Medical literature suggests a strong biologic plausibility between opioid analgesics and OIH and allodynia. If concomitant use is warranted, consider prescribing naloxone for the emergency treatment of opioid overdose [see Dosage and Administration (2.2), Warnings and Precautions (5.3), Overdosage (10)]. Opioids can cause sleep-related breathing disorders including central sleep apnea (CSA) and sleep-related hypoxemia. Opioid use increases the risk of CSA in a dose-dependent fashion.

Never crush or break a hydromorphone pill to inhale the powder or mix it into a liquid to inject the drug into your vein. Long-term use of opioid medication may affect fertility (ability to have children) in men or women. It is not known whether opioid effects on fertility are permanent. Your doctor may start you on a lowered dosage or a different schedule.

Misuse and abuse of DILAUDID INJECTION increases risk of overdose, which may lead to central nervous system and respiratory depression, hypotension, seizures, and death. The risk is increased with concurrent abuse of DILAUDID INJECTION with alcohol and/or other CNS depressants. Because of these supporting those in recovery during the holidays risks, reserve concomitant prescribing of these drugs for use in patients for whom alternative treatment options are inadequate. In contrast, medical use of opioids has little to do with the overdose epidemic. Patients prescribed these drugs for pain management generally don’t abuse them.

Keep this medicine in a safe place to prevent theft, misuse, or abuse. If someone accidentally swallows this drug, get medical help right away. Remember that this medication has been prescribed because your doctor has judged that the benefit to you is greater than the risk of side effects. Many people using this medication do not have serious side effects. If you are using the liquid form of this medication, carefully measure the dose using a special measuring device/spoon.

Careful record-keeping of prescribing information, including quantity, frequency, and renewal requests, as required by state and federal law, is strongly advised. DILAUDID Oral Solution or DILAUDID Tablets may impair the mental or physical abilities needed to perform potentially hazardous activities such as driving a car or operating machinery. Warn patients not to drive or operate dangerous machinery unless they are tolerant to the effects of DILAUDID Oral Solution or DILAUDID Tablets and know how they will react to the medication. Initiate treatment with one-fourth to one-half the usual DILAUDID starting dose depending on the degree of impairment [see Use in Specific Populations (8.7), and Clinical Pharmacology (12.3)]. Initiate treatment with one-fourth to one-half the usual DILAUDID starting dose depending on the degree of impairment [see Use in Specific Populations (8.6), and Clinical Pharmacology (12.3)]. Inform patients and caregivers that oral dosing devices may be obtained from their pharmacy and to never use household teaspoons or tablespoons to measure DILAUDID Oral Solution.